Farsight Genome Systems Revenue and Competitors
Estimated Revenue & Valuation
- Farsight Genome Systems's estimated annual revenue is currently $775k per year.
- Farsight Genome Systems's estimated revenue per employee is $155,000
Employee Data
- Farsight Genome Systems has 5 Employees.
- Farsight Genome Systems grew their employee count by -17% last year.
Farsight Genome Systems's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and founder | Reveal Email/Phone |
Farsight Genome Systems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Farsight Genome Systems?
Farsight Genome Systems has developed an innovative SaaS solution for health systems providing genetic/genomic testing as part of precision medicine programs. The API architecture integrates readily into existing LIS/EMR software, providing enterprise-wide genomic data management with on-demand re-analysis and re-interpretation. End-user laboratories select from a portfolio of in silico, multi-gene Testpanels to control indication-specific analysis and reporting. The Farsight Genome Systems solution accelerates adoption of recommended genomic testing from evidence-based clinical practice guidelines.
keywords:N/A
N/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 5 | -29% | $3M |
#2 | $0.8M | 5 | 0% | N/A |
#3 | $0.1M | 5 | 25% | $80M |
#4 | $0.1M | 5 | 0% | $13.1M |
#5 | $0.1M | 5 | -17% | $4.7M |